VICE PRESIDENT SEVERANCE AGREEMENTSeverance Agreement • March 14th, 2016 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
This Vice President Severance Agreement (the “Agreement”) is entered into as of January 14, 2016 (the “Effective Date”) by and between Henry L. Hebel (the “Employee”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).
SPONSORED RESEARCH AGREEMENT NO. UTA13-001113Sponsored Research Agreement • March 14th, 2016 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
This Sponsored Research Agreement (“Agreement”) is made between The University of Texas at Austin, Austin, Texas (“University”), an institution of higher education created by the Constitution and law of the State of Texas under The University of Texas System (“System”) and Aeglea Development Company, Inc., AERase, Inc., AEMase, Inc., AECase, Inc., AE4ase, Inc., AE5ase, Inc., and AE6ase, Inc., all Delaware C corporations with their principal place of business at 815 A Brazos St., #101, Austin TX 78701 (each a “Sponsor Entity” and collectively, “Sponsor”). Aeglea Development Company, Inc. may be referred to herein as the “Funding Sponsor” or “Sponsor Entity” as appropriate.
